Literature DB >> 11706778

Updated statistical data for malignant melanoma in Japan.

K Ishihara1, T Saida, A Yamamoto.   

Abstract

BACKGROUND: A statistical investigation was conducted of Japanese melanoma patients who had been registered by the Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society. The data were obtained from 24 main medical institutions in Japan in the period 1987 to 1996. The patients were classified into two chronological groups; group A, 535 patients registered from 1987 to 1991; and group B, 639 patients registered from 1992 to 1996. As the preliminary data for group A has been reported previously (Gann Monograph on Cancer Research 43), in this report, the survival data of group B were assessed, and compared with the data for group A.
METHODS: The data analyzed included age, sex, anatomical distribution, clinical features of primary lesions, Clark's subtype, tumor thickness, Clark's level, disease stage, and treatment. The survival rate was assessed by the Kaplan-Meier method, and the significance of differences was determined with the log-rank test. In addition, the results of a nationwide survey of various types of skin malignancies, obtained from 101 medical institutions in Japan between 1987 and 1996, were analyzed.
RESULTS: The nationwide survey revealed that the number of patients with malignant melanoma showed a steady increase during the period 1987-1996 in Japan. It is noteworthy that the numbers of actinic keratoses, a type of early squamous cell carcinoma in situ, showed a steep increase in recent years. Results revealed in our study of the melanoma registry for the period 1987-1996 were as follows: (1) the male-to-female ratio was 1 to 1.06, (2) the survival rate of female patients was higher than that of male patients (10-year survival in group B: female, 71.6% vs male, 55.9%), (3) the commonest site of melanoma in both sexes was the sole of the foot, (4) with respect to Clark's subtype, acral lentiginous melanoma was commonest, accounting for about half of all melanomas, (5) nodular melanoma showed the worst prognosis among the subtypes, (6) patients in stage IIIB and stage IV had an unfavorable outcome, with 10-year survivals of less than 50% and less than 10%, respectively, (7) Clark's level of invasion, as well as Breslow's tumor thickness of the primary lesions, were confirmed to be important prognostic factors, and (8) prophylactic lymph node dissection in stage II and IIIA and chemotherapy in stage IV seemed to have limited effect on the prognosis.
CONCLUSION: The prognosis of advanced melanoma is poor, as it is highly resistant to chemotherapy. Thus, to improve the prognosis, early detection is mandatory, and this is possible because this neoplasm appears as a distinctive pigmented lesion on the skin.

Entities:  

Mesh:

Year:  2001        PMID: 11706778     DOI: 10.1007/pl00012091

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  29 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

Review 2.  Improving the diagnosis and treatment of acral melanocytic lesions.

Authors:  Maressa C Criscito; Jennifer A Stein
Journal:  Melanoma Manag       Date:  2017-05-19

3.  Acculturation, Skin Tone Preferences, and Tanning Behaviours Among Young Adult Asian Australians.

Authors:  Ashley K Day; Carlene J Wilson; Amanda D Hutchinson; Rachel M Roberts
Journal:  J Prim Prev       Date:  2016-10

4.  Case report: Dermoscopic and histological aspects of skin graft and perigraft hyperpigmentation in acral location.

Authors:  Bruna Tuma; Sergio Yamada; Rodrigo Almeida de Medeiros; Mauricio Mendonca do Nascimento; Sergio Henrique Hirata
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

5.  Treatment and outcomes of melanoma in acral location in Korean patients.

Authors:  Mi Ryung Roh; Jihyun Kim; Kee Yang Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

6.  Clinical guidelines for the recognition of melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker; Katharine M Acland; Richard J Turner; Jonathan Bowling
Journal:  J Foot Ankle Res       Date:  2010-11-01       Impact factor: 2.303

7.  Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).

Authors:  Minhyung Kim; Asher B Blum; Michelle L Haslinger; Michael J Donahue; Daniel T Fisher; Joseph J Skitzki; Il Young Park
Journal:  Surg Today       Date:  2014-07-08       Impact factor: 2.549

8.  Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.

Authors:  Kazuyuki Ishihara; Toshiaki Saida; Fujio Otsuka; Naoya Yamazaki
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

9.  A rare form of melanoma masquerading as a diabetic foot ulcer: a case report.

Authors:  Susan Thomas; Yuan-Xiang Meng; Vijaykumar G Patel; Gregory Strayhorn
Journal:  Case Rep Endocrinol       Date:  2012-04-04

10.  Acral melanoma with hyperkeratosis mimicking a pigmented wart.

Authors:  Misaki Ise; Fumiyo Yasuda; Izumi Konohana; Keiko Miura; Masaru Tanaka
Journal:  Dermatol Pract Concept       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.